Search - tctmd.com

Displaying 201 - 220 of 320

Sort: Relevancy | Date

News Conference News AHA 2020

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

Todd Neale

November 13, 2020

News Conference News TCT 2020

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Shelley Wood

October 16, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Conference News HFSA 2020

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

L.A. McKeown

October 09, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Conference News ESC 2020

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

Todd Neale

August 30, 2020

News Conference News ESC 2020

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

Michael O'Riordan

August 28, 2020

News Daily News

Super-Responders in COAPT: Improving MR and QoL Is Key

Shelley Wood

August 24, 2020

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

Too Many HF Trial Results Underreported or Never Published

L.A. McKeown

June 23, 2020

News Conference News HRS 2020

Subcutaneous ICD Holds Up Well Against Transvenous Devices

Todd Neale

May 13, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Shelley Wood

March 10, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Daily News

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

Shelley Wood

January 24, 2020

News Daily News

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Caitlin E. Cox

January 20, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

L.A. McKeown

December 06, 2019

Advertisement

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

Super-Responders in COAPT: Improving MR and QoL Is Key

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Too Many HF Trial Results Underreported or Never Published

Subcutaneous ICD Holds Up Well Against Transvenous Devices

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content